HBM Holdings-B (02142) spent HKD 322,300 to repurchase 110,000 shares on January 21.
Boehringer Ingelheim-B (02142) announced that the company invested HKD 322,300 on January 21, 2025.
HBM HOLDINGS-B (02142) announced that on January 21, 2025, the company repurchased 110,000 shares at a price of HK$2.93 per share, totaling HK$322,300.
On the same day, 26,000 ordinary shares were issued to meet the share incentive plan adopted and approved by the company shareholders on November 23, 2020.
Related Articles

BUD APAC (01876) announced its annual performance for the year 2025, with net profit attributable to equity holders decreasing by 32.6% to 489 million US dollars compared to the previous year.

New Stock News | Zhejiang Jingxin Pharmaceutical(002020.SZ) submits application to Hong Kong Stock Exchange, focusing on diseases of the central nervous system, cardiovascular, and cerebrovascular system.

CMSC: Hang Seng Technology has great allocation value at the current position. It is recommended to buy on dips and hold during the holidays.
BUD APAC (01876) announced its annual performance for the year 2025, with net profit attributable to equity holders decreasing by 32.6% to 489 million US dollars compared to the previous year.

New Stock News | Zhejiang Jingxin Pharmaceutical(002020.SZ) submits application to Hong Kong Stock Exchange, focusing on diseases of the central nervous system, cardiovascular, and cerebrovascular system.

CMSC: Hang Seng Technology has great allocation value at the current position. It is recommended to buy on dips and hold during the holidays.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


